Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2720 Results
Five insights into how the brain works
Person sitting at a table with blurry people in front and a screen hanging on the wall behind, which reads, "Experiential effects on brain development."

Martha J. Farah, the Annenberg Professor of Natural Sciences, is director of the Center for Neuroscience & Society at Penn. (Pre-pandemic image: Courtesy Martha Farah) 

Five insights into how the brain works

As the Center for Neuroscience & Society celebrates 10 years, founding director Martha Farah reflects on the array of research from its faculty, on subjects from brain games to aggression.

Michele W. Berger

Looking into the immune system to better fight disease
a gloved hand holds a glass film with blood sample underneath beneath a microscope

Looking into the immune system to better fight disease

A rare, short-lived population of immune cells in the bloodstream may serve as ‘periscopes’ to monitor immune status via lymph nodes deep inside the body, researchers say.

Penn Today Staff

Blinking eye-on-a-chip used for disease modeling and drug testing
The Huh lab’s eye-on-a-chip attached to a motorized, gelatin-based eyelid.

The Huh lab’s eye-on-a-chip attached to a motorized, gelatin-based eyelid. (Image: Penn Engineering)

Blinking eye-on-a-chip used for disease modeling and drug testing

Penn Engineering’s Dan Huh and Jeongyun Seo built an eye model that could imitate a healthy eye and an eye with dry eye disease, allowing them to test an experimental drug without risk of human harm.

Penn Today Staff

The brain’s amyloid buildup is not a powerful indicator of Alzheimer’s disease
Three stages of Alzheimers portrayed by three scans of neurons

The brain’s amyloid buildup is not a powerful indicator of Alzheimer’s disease

Researchers find fluorodeoxyglucose (FDG) PET, which measures the brain’s glucose consumption as a marker of neural activity, is a better indicator of cognitive performance when compared to PET scans that detect amyloid proteins.

Penn Today Staff

A cohort study comes of age
illustration of kidneys

A cohort study comes of age

For nearly two decades, a major national study of kidney disease led and coordinated at Penn has defined key risk factors in an all-too-common silent epidemic.

Steve Graff

Sun, sand, and medical rehab robots
A smiling person sits as one person touches his closed hand, another looks at part of a robotic device, and a third looks on at a laptop on a table in a medical room.

Three students in the Penn Global Seminar “Robotics and Rehabilitation” fit a Jamaican man (left) with a robotic device that may help him grasp objects in a hand that lost some capabilities following a stroke. (Photo: Jacob Gross)

Sun, sand, and medical rehab robots

As part of a new interdisciplinary Penn Global Seminar, 16 undergraduates traveled to Jamaica to test and refine robotic rehabilitation devices for patients in need.

Gina Vitale , Michele W. Berger

Nursing home nurses lack time and resources for complete care
person in wheelchair looks out the window, elder in an eldercare facility with a lack of nurses present.

Nursing home nurses lack time and resources for complete care

Evidence from hospitals has shown for years that nurses are more likely to leave necessary patient care undone when employed in settings with insufficient staff and resources. This “missed care” has been linked to poor care quality.

Penn Today Staff

Brain matter altered in U.S. personnel who developed neurological symptoms in Cuba
20 brain scans showing regions affected by neurological damage.

The colored regions in these images show differences on the group level—or averages—widespread throughout the brain, and particularly in the cerebellum, which is responsible for balance, coordination, and speech. (Image: JAMA Network)

Brain matter altered in U.S. personnel who developed neurological symptoms in Cuba

Images reveal key brain differences, particularly in the cerebellum, between impacted patients and healthy individuals, which may underlie clinical findings previously reported by the Penn team.

Penn Today Staff

A new cancer drug, thanks to a new approach
A rendering of a plasma cell lymphocyte.

A new cancer drug, thanks to a new approach

Researchers in the Abramson Cancer Center helped bring new hope to patients with multiple myeloma with a drug that targets the command center of a cancer cell.

Penn Today Staff